Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
Multiple sclerosis.
Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding.
Remyelination by Resident Oligodendrocyte Precursor Cells in a Xenopus laevis Inducible Model of Demyelination.
Natalizumab treatment for multiple sclerosis inducing a toxic acute myocardial damage. Is there any relationship?
[Clinical significance of T-regulatory cells in multiple sclerosis.]
Clinical designs of recent robot rehabilitation trials.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
Research Advances in Biomarkers for Demyelinating Optic Neuritis.
[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data.]
Factors associated with health-related quality of life among older people with multiple sclerosis.
Structural Biology of the S1P1 Receptor.
Diet, microbiota and autoimmune diseases.
Co-Existence of Familial Mediterranean Fever and Multiple Sclerosis in Two Patients.
LEBER'S DISEASE WITH SYMPTOMS RESEMBLING DISSEMINATED SCLEROSIS.
Spousal support as experienced by people with multiple sclerosis: a qualitative study.
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.
Smokers run increased risk of developing anti-natalizumab antibodies.
Evaluation of new immunological targets in neuromyelitis optica.
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Patient autonomy in multiple sclerosis - Possible goals and assessment strategies.
Cell-based therapy approaches: the hope for incurable diseases.

Pages